Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab and FOLFIRINOX in First-Line Metastatic Colorectal Cancer
NCT00556413Phase 2Completed
- Sponsor
- Institut du Cancer de Montpellier
- Start
- Sep 2005
- Primary completion
- May 2011
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in colorectal cancer (CRC), sponsored by Institut du Cancer de Montpellier. Started Sep 2005; status: completed.
02
Drugs
cetuximab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00556413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00556413.